L'épuration extrarénale appliquée au patient hospitalisé aux soins intensifs

[en] Mortality remains high in intensive care patients with renal failure requiring extra corporeal blood purification. This article reviews the recent data that have led to the improvement of the care for such patients. We will discuss the criteria to determine the choice of the technique (intermittent or continuous), of the membrane, of the prescribing dose, and the type of anticoagulation and when to initiate such a treatment.

Disciplines :

Urology & nephrology

Author, co-author :

Delanaye, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie

Dubois, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie

Lambermont, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > Frais communs médecine

Krzesinski, Jean-Marie ; Université de Liège - ULiège > Département des sciences cliniques > Néphrologie

Language :

French

Title :

L'épuration extrarénale appliquée au patient hospitalisé aux soins intensifs

Alternative titles :

[en] Extracorporeal Blood Purification in the Intensive Care Units

Publication date :

July 2007

Journal title :

Néphrologie et Thérapeutique

ISSN :

1769-7255

eISSN :

1872-9177

Publisher :

Elsevier Masson, Netherlands

Volume :

Issue :

Pages :

126-32

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

http://www.elsevier.com/wps/find/journaldescription.cws_home/705443/description#description

Commentary :

All our thank to Elsevier

Available on ORBi :

since 16 February 2009

Statistics

Number of views

79 (8 by ULiège)

Number of downloads

1312 (23 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Lameire N., Van Biesen W., and Vanholder R. Acute renal failure. Lancet 365 (2005) 417-430
Metnitz P.G., Krenn C.G., Steltzer H., Lang T., Ploder J., Lenz K., et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit. Care Med. 30 (2002) 2051-2058
Waikar S.S., Curhan G.C., Wald R., McCarthy E.P., and Chertow G.M. Declining mortality in patients with acute renal failure, 1988 to 2002. J. Am. Soc. Nephrol. 17 (2006) 1143-1150
Xue J.L., Daniels F., Star R.A., Kimmel P.L., Eggers P.W., Molitoris B.A., et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J. Am. Soc. Nephrol. 17 (2006) 1135-1142
Brivet F.G., Kleinknecht D.J., Loirat P., and Landais P.J. Acute renal failure in intensive care units-causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Crit. Care Med. 24 (1996) 192-198
Chew S.L., Lins R.L., Daelemans R., and De Broe M.E. Outcome in acute renal failure. Nephrol. Dial. Transplant. 8 (1993) 101-107
Phu N.H., Hien T.T., Mai N.T., Chau T.T., Chuong L.V., Loc P.P., et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N. Engl. J. Med. 347 (2002) 895-902
Manns M., Sigler M.H., and Teehan B.P. Continuous renal replacement therapies: an update. Am. J. Kidney Dis. 32 (1998) 185-207
Mehta R.L. Continuous renal replacement therapy in the critically ill patient. Kidney Int. 67 (2005) 781-795
Bellomo R., Farmer M., Bhonagiri S., Porceddu S., Ariens M., M'Pisi D., et al. Changing acute renal failure treatment from intermittent hemodialysis to continuous hemofiltration: impact on azotemic control. Int. J. Artif. Organs 22 (1999) 145-150
Uchino S., Bellomo R., and Ronco C. Intermittent versus continuous renal replacement therapy in the ICU: impact on electrolyte and acid-base balance. Intensive Care Med. 27 (2001) 1037-1043
Van Laecke S., De Wilde K., and Vanholder R. Online hemodiafiltration. Artif. Organs 30 (2006) 579-585
Uchino S., Fealy N., Baldwin I., Morimatsu H., and Bellomo R. Continuous is not continuous: the incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med. 29 (2003) 575-578
Schortgen F., Soubrier N., Delclaux C., Thuong M., Girou E., Brun-Buisson C., et al. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulness of practice guidelines. Am. J. Respir. Crit. Care Med. 162 (2000) 197-202
Misset B., Timsit J.F., Chevret S., Renaud B., Tamion F., and Carlet J. A randomized cross-over comparison of the hemodynamic response to intermittent hemodialysis and continuous hemofiltration in ICU patients with acute renal failure. Intensive Care Med. 22 (1996) 742-746
Manns B., Doig C.J., Lee H., Dean S., Tonelli M., Johnson D., et al. Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit. Care Med. 31 (2003) 449-455
Swartz R.D., Messana J.M., Orzol S., and Port F.K. Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure. Am. J. Kidney Dis. 34 (1999) 424-432
Mehta R.L., McDonald B., Gabbai F.B., Pahl M., Pascual M.T., Farkas A., et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int. 60 (2001) 1154-1163
Guerin C., Girard R., Selli J.M., and Ayzac L. Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: results from a multicenter prospective epidemiological survey. Intensive Care Med. 28 (2002) 1411-1418
Neveu H., Kleinknecht D., Brivet F., Loirat P., and Landais P. Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol. Dial. Transplant. 11 (1996) 293-299
Kierdorf H. Continuous versus intermittent treatment: clinical results in acute renal failure. Contrib. Nephrol. 93 (1991) 1-12
Ji D., Gong D., Xie H., Xu B., Liu Y., and Li L. A retrospective study of continuous renal replacement therapy versus intermittent hemodialysis in severe acute renal failure. Chin. Med. J. (Engl.) 114 (2001) 1157-1161
Kruczynski K., Irvine-Bird K., Toffelmire E.B., and Morton A.R. A comparison of continuous arteriovenous hemofiltration and intermittent hemodialysis in acute renal failure patients in the intensive care unit. ASAIO J. 39 (1993) M778-M781
Tonelli M., Manns B., and Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am. J. Kidney Dis. 40 (2002) 875-885
Kellum J.A., Angus D.C., Johnson J.P., Leblanc M., Griffin M., Ramakrishnan N., et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med. 28 (2002) 29-37
Augustine J.J., Sandy D., Seifert T.H., and Paganini E.P. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am. J. Kidney Dis. 44 (2004) 1000-1007
Uehlinger D.E., Jakob S.M., Ferrari P., Eichelberger M., Huynh-Do U., Marti H.P., et al. Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol. Dial. Transplant. 20 (2005) 1630-1637
Vinsonneau C., Camus C., Combes A., Costa de Beauregard M.A., Klouche K., Boulain T., et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 368 (2006) 379-385
Fliser D., and Kielstein J.T. Technology Insight: treatment of renal failure in the intensive care unit with extended dialysis. Nat. Clin. Pract. Nephrol. 2 (2006) 32-39
Hakim R.M. Clinical implications of hemodialysis membrane biocompatibility. Kidney Int. 44 (1993) 484-494
Chenoweth D.E. Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications. Artif. Organs 8 (1984) 281-290
Schulman G., Fogo A., Gung A., Badr K., and Hakim R. Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int. 40 (1991) 1069-1074
Schiffl H., Lang S.M., Konig A., Strasser T., Haider M.C., and Held E. Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet 344 (1994) 570-572
Himmelfarb J., Tolkoff R.N., Chandran P., Parker R.A., Wingard R.L., and Hakim R. A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis. J. Am. Soc. Nephrol. 9 (1998) 257-266
Jorres A., Gahl G.M., Dobis C., Polenakovic M.H., Cakalaroski K., Rutkowski B., et al. Haemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: a prospective randomised multicentre trial. International Multicentre Study Group. Lancet 354 (1999) 1337-1341
Gastaldello K., Melot C., Kahn R.J., Vanherweghem J.L., Vincent J.L., and Tielemans C. Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Nephrol. Dial. Transplant. 15 (2000) 224-230
Kurtal H., von Herrath D., and Schaefer K. Is the choice of membrane important for patients with acute renal failure requiring hemodialysis?. Artif. Organs 19 (1995) 391-394
Schiffl H. Biocompatibility and acute renal failure. Lancet 355 (2000) 312-314
Vanholder R., and Lameire N. Does biocompatibility of dialysis membranes affect recovery of renal function and survival?. Lancet 354 (1999) 1316-1318
Subramanian S., Venkataraman R., and Kellum J.A. Influence of dialysis membranes on outcomes in acute renal failure: a meta-analysis. Kidney Int. 62 (2002) 1819-1823
Jaber B.L., Lau J., Schmid C.H., Karsou S.A., Levey A.S., and Pereira B.J. Effect of biocompatibility of hemodialysis membranes on mortality in acute renal failure: a meta-analysis. Clin. Nephrol. 57 (2002) 274-282
Gillum D.M., Dixon B.S., Yanover M.J., Kelleher S.P., Shapiro M.D., Benedetti R.G., et al. The role of intensive dialysis in acute renal failure. Clin. Nephrol. 25 (1986) 249-255
Storck M., Hartl W.H., Zimmerer E., and Inthorn D. Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 337 (1991) 452-455
Paganini E.P., Tapolyai M., and Goormastic M. Establishing a dialysis/patient outcome link in intensive care unit acute dialysis for patients with acute renal failure. Am. J. Kidney Dis. 28 (1996) S81-S89
Ikizler T.A., Sezer M.T., Flakoll P.J., Hariachar S., Kanagasundaram N.S., Gritter N., et al. Urea space and total body water measurements by stable isotopes in patients with acute renal failure. Kidney Int. 65 (2004) 725-732
Evanson J.A., Himmelfarb J., Wingard R., Knights S., Shyr Y., Schulman G., et al. Prescribed versus delivered dialysis in acute renal failure patients. Am. J. Kidney Dis. 32 (1998) 731-738
Kanagasundaram N.S., Greene T., Larive A.B., Daugirdas J.T., Depner T.A., Garcia M., et al. Prescribing an equilibrated intermittent hemodialysis dose in intensive care unit acute renal failure. Kidney Int. 64 (2003) 2298-2310
Ronco C., Bellomo R., Homel P., Brendolan A., Dan M., Piccinni P., et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356 (2000) 26-30
Bellomo R. Do we know the optimal dose for renal replacement therapy in the intensive care unit?. Kidney Int. 70 (2006) 1202-1204
Clark W.R., Turk J.E., Kraus M.A., and Gao D. Dose determinants in continuous renal replacement therapy. Artif. Organs 27 (2003) 815-820
Honore P.M., Jamez J., Wauthier M., Lee P.A., Dugernier T., Pirenne B., et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit. Care Med. 28 (2000) 3581-3587
Piccinni P., Dan M., Barbacini S., Carraro R., Lieta E., Marafon S., et al. Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med. 32 (2006) 80-86
Joannes-Boyau O., Rapaport S., Bazin R., Fleureau C., and Janvier G. Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J. 50 (2004) 102-109
Schiffl H., Lang S.M., and Fischer R. Daily hemodialysis and the outcome of acute renal failure. N. Engl. J. Med. 346 (2002) 305-310
Lautrette A., and Schortgen F. La dose de dialyse en réanimation. Réanimation 14 (2006) 499-507
Davenport A. The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit. Am. J. Kidney Dis. 30 (1997) S20-S27
Kaplan A.A., Longnecker R.E., and Folkert V.W. Continuous arteriovenous hemofiltration. A report of six months' experience. Ann. Intern. Med. 100 (1984) 358-367
Samuelsson O., Amiral J., Attman P.O., Bennegard K., Bjorck S., Larsson G., et al. Heparin-induced thrombocytopenia during continuous haemofiltration. Nephrol. Dial. Transplant. 10 (1995) 1768-1771
Vargas H.O., von Heymann C., Lipps M., Ziemer S., Ronco C., Neumayer H.H., et al. Hirudin versus heparin for anticoagulation in continuous renal replacement therapy. Intensive Care Med. 27 (2001) 673-679
Ponikvar R., Kandus A., Buturovic J., and Kveder R. Use of prostacyclin as the only anticoagulant during continuous venovenous hemofiltration. Contrib. Nephrol. 93 (1991) 218-220
Kaplan A.A., and Petrillo R. Regional heparinization for continuous arteriovenous hemofiltration (CAVH). ASAIO Trans. 33 (1987) 312-315
Uchino S., Fealy N., Baldwin I., Morimatsu H., and Bellomo R. Continuous venovenous hemofiltration without anticoagulation. ASAIO J. 50 (2004) 76-80
Tan H.K., Baldwin I., and Bellomo R. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med. 26 (2000) 1652-1657
Brophy P.D., Somers M.J., Baum M.A., Symons J.M., McAfee N., Fortenberry J.D., et al. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol. Dial. Transplant. 20 (2005) 1416-1421
Dorval M., Madore F., Courteau S., and Leblanc M. A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration. Intensive Care Med. 29 (2003) 1186-1189
Gupta M., Wadhwa N.K., and Bukovsky R. Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate. Am. J. Kidney Dis. 43 (2004) 67-73
Kutsogiannis D.J., Gibney R.T., Stollery D., and Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int. 67 (2005) 2361-2367
Monchi M., Berghmans D., Ledoux D., Canivet J.L., Dubois B., and Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med. 30 (2004) 260-265
Palsson R., and Niles J.L. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int. 55 (1999) 1991-1997
Mehta R.L., McDonald B.R., Aguilar M.M., and Ward D.M. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int. 38 (1990) 976-981
de Pont A.C., Bouman C.S., de Jonge E., Vroom M.B., Buller H.R., and Levi M. Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis. Intensive Care Med. 29 (2003) 1205
Gettings L.G., Reynolds H.N., and Scalea T. Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early versus late. Intensive Care Med. 25 (1999) 805-813
Parsons F.M., Hobson S.M., Blagg C.R., and McCracken B.H. Optimum time for dialysis in acute reversible renal failure. Description and value of an improved dialyser with large surface area. Lancet 1 (1961) 129-134
Kleinknecht D., Jungers P., Chanard J., Barbanel C., Ganeval D., and Rondon-Nucete M. Factors influencing immediate prognosis in acute renal failure, with special reference to prophylactic hemodialysis. Adv. Nephrol. Necker Hosp. 1 (1971) 207-230
Conger J.D. A controlled evaluation of prophylactic dialysis in post-traumatic acute renal failure. J. Trauma 15 (1975) 1056-1063
Bent P., Tan H.K., Bellomo R., Buckmaster J., Doolan L., Hart G., et al. Early and intensive continuous hemofiltration for severe renal failure after cardiac surgery. Ann. Thorac. Surg. 71 (2001) 832-837
Elahi M.M., Lim M.Y., Joseph R.N., Dhannapuneni R.R., and Spyt T.J. Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure. Eur. J. Cardiothorac. Surg. 26 (2004) 1027-1031
Guerin C., Girard R., Selli J.M., Perdrix J.P., and Ayzac L. Initial versus delayed acute renal failure in the intensive care unit. A multicenter prospective epidemiological study. Rhone-Alpes Area Study Group on Acute Renal Failure. Am. J. Respir. Crit. Care Med. 161 (2000) 872-879
Teschan P.E., Baxter C.R., O'Brien T.F., Freyhof J.N., and Hall W.H. Prophylactic hemodialysis in the treatment of acute renal failure. Ann. Intern. Med. 53 (1960) 992-1016
Fischer R.P., Griffen Jr. W.O., Reiser M., and Clark D.S. Early dialysis in the treatment of acute renal failure. Surg. Gynecol. Obstet. 123 (1966) 1019-1023
McCarthy J.T. Prognosis of patients with acute renal failure in the intensive-care unit: a tale of two eras. Mayo Clin. Proc. 71 (1996) 117-126
Hoste E.A., Damen J., Vanholder R.C., Lameire N.H., Delanghe J.R., Van den Hauwe K., et al. Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol. Dial. Transplant. 20 (2005) 747-753
Mehta R.L., and Chertow G.M. Acute renal failure definitions and classification: time for change?. J. Am. Soc. Nephrol. 14 (2003) 2178-2187
Bellomo R., Ronco C., Kellum J.A., Mehta R.L., and Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 8 (2004) R204-R212
Delanaye P., Lambermont B., Chapelle J.P., Gielen J., Gerard P., and Rorive G. Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units. Intensive Care Med. 30 (2004) 980-983
Herget-Rosenthal S., Marggraf G., Husing J., Goring F., Pietruck F., Janssen O., et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 66 (2004) 1115-1122
Le Bricon T., Leblanc I., Benlakehal M., Gay-Bellile C., Erlich D., and Boudaoud S. Evaluation of renal function in intensive care: plasma cystatin C versus creatinine and derived glomerular filtration rate estimates. Clin. Chem. Lab. Med. 43 (2005) 953-957
Mishra J., Dent C., Tarabishi R., Mitsnefes M.M., Ma Q., Kelly C., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365 (2005) 1231-1238